P. Akkus Gunduz Et Al. , "Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study," Nuclear Medicine Communications , vol.44, no.2, pp.150-160, 2023
Akkus Gunduz, P. Et Al. 2023. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study. Nuclear Medicine Communications , vol.44, no.2 , 150-160.
Akkus Gunduz, P., ÖZKAN, E., KURU ÖZ, D., SOYDAL, Ç., ARAZ, M., ERDEN, G. A., ... YAVUZ, Y.(2023). Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study. Nuclear Medicine Communications , vol.44, no.2, 150-160.
Akkus Gunduz, Pinar Et Al. "Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study," Nuclear Medicine Communications , vol.44, no.2, 150-160, 2023
Akkus Gunduz, Pinar A. Et Al. "Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study." Nuclear Medicine Communications , vol.44, no.2, pp.150-160, 2023
Akkus Gunduz, P. Et Al. (2023) . "Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study." Nuclear Medicine Communications , vol.44, no.2, pp.150-160.
@article{article, author={Pinar Akkus Gunduz Et Al. }, title={Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: A prospective study}, journal={Nuclear Medicine Communications}, year=2023, pages={150-160} }